102 articles
o9 Solutions announces that Teleflex, a global leader in medical technology, has successfully gone live with global demand and supply planning using the o9 Digital Brain platform. This implementation is part of Teleflex's multi-year initiative to advance its end-to-end integrated business planning and SCM capabilities.
Berry will showcase 'QMSmart,' a cloud-based eQMS developed from a field perspective by a medical device manufacturer, at Medtec Japan 2026, Asia's largest exhibition for medical device manufacturing and design.
Molex has acquired Smiths Interconnect, expanding its portfolio and expertise in high-reliability markets such as aerospace, defense, medical, and semiconductor test, and strengthening its global manufacturing and design capabilities.
Splink Inc. announces its dream to make "brain healthcare" a global standard, aiming for a dementia-free society.
Medcuration's April Dream is to make NIPP, a catheter treatment for pelvic cancer, accessible to all patients by achieving insurance coverage by 2030.
Physiologas Technologies Inc. has completed the third close of its Series A funding round, securing investment from Toyota Coniq Corporation. This funding will accelerate the development of home hemodialysis products aimed at improving the quality of life for end-stage renal disease patients and their families.
Orcoa Inc. will exhibit at Wellness Weekend NAGOYA, featuring their oral bacteria detection device and the popular 'Periodontal Disease Mirror'.
Coretrim Station has registered a low back pain prevention exercise course with Yokohama City's "Hama-Yell" program, supporting the health of women in the child-rearing generation.
HICKY, a developer of innovative treatment devices for central sleep apnea, has raised funds to accelerate the development of its stent-type, wireless-powered neurostimulation device.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
GE HealthCare Japan announces the appointment of Mai Goto as CFO, effective April 1, 2026.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
A small company with a big wish—'Supporting workers more'—will run on the Yamanote Line tomorrow.
Accelerating global expansion and M&A exit by enhancing the safety of gastrointestinal treatment with the world's first 'anchor technology'.
Accelerating global expansion and M&A exit by enhancing the safety of gastrointestinal treatment with the world's first 'anchor technology'.
Mitsubishi UFJ Capital has invested in KOEDA, a startup developing organ-anchoring devices for endoscopic treatment.
Accelerating global expansion and M&A exit by enhancing the safety of gastrointestinal treatment with the world's first 'anchor technology'.
Accelerating global expansion and M&A exit by enhancing the safety of gastrointestinal treatment with the world's first 'anchor technology'.
Solventum has announced the appointment of Masaru Taguchi as the new representative for its five Japanese entities, effective April 1, 2026.
Pip launches the magnetic therapy device 'Pip Vocaburaban,' advertised to relieve 'brain stiffness.'
Nidek has launched the 'Open Field Refraction System PHANTOM™', a novel eye examination device that conducts vision and refraction tests without obstructing the patient's view, allowing for binocular measurement. This innovation aims to address the global rise in myopia and improve patient comfort by eliminating the stress associated with traditional monocular eye exams, promising more natural and accurate results.
Nihon Kohden Corporation has adopted "LegalOn", an AI agent specialized for legal affairs provided by LegalOn Technologies, to streamline contract review processes and enhance compliance.
Sweet Co., Ltd. announces the launch of the new contact lens brand 'HAIDEY' featuring artist Nissy. The brand introduces the concept of 'Impression Correction Lenses' that bring out the natural charm of the eyes, launching on April 6, 2026.
Wuding announced its monthly revenue for March 2026 was NT$141 million, representing a significant year-on-year decrease of 24.1%. This data provides key insights into the company's performance within the biotech and medical industry.